Identifying Good Candidates for Histotripsy to Treat Liver Tumors
Histotripsy suits patients with good health, normal liver, and small tumors; it's part of a broader plan, not a cancer care replacement.
Shaun P. McKenzie, M.D., FACS, Texas Oncology Surgical Specialists–Round Rock and South Austin, explains that certain patient characteristics, such as normal liver function and overall health, play crucial roles in determining candidacy for histotripsy, a liver-directed treatment, which is not a replacement for existing cancer care methods. He also emphasizes that this treatment should be integrated into a comprehensive treatment plan and is ideally suited for tumors under 4 centimeters, while cases of spread beyond the liver must be carefully managed by a multidisciplinary team.
Read the full story in American Journal of Managed Care.